Eterna Therapeutics Inc (ERNA) — Cash Flow-to-Debt Ratio
Eterna Therapeutics Inc (ERNA) has a Cash Flow-to-Debt Ratio of -1.33x as of June 2026, meaning its operating cash flow of $-4.15 Million could theoretically repay -1% of its total liabilities ($3.12 Million) in one year. See financial flexibility index of Eterna Therapeutics Inc to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Eterna Therapeutics Inc Cash Flow-to-Debt Ratio (2007–2025)
Historical debt coverage capacity for Eterna Therapeutics Inc across 18 annual periods. For the full cash flow conversion analysis, see Eterna Therapeutics Inc operating cash flow efficiency.
Annual Cash Flow-to-Debt Ratio for Eterna Therapeutics Inc (2007–2025)
Year-by-year debt coverage analysis for Eterna Therapeutics Inc. Check earnings quality score of Eterna Therapeutics Inc to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -2.04x | $-7.02 Million | $3.43 Million | ▲ +53.9% |
| 2024 | -4.44x | $-15.84 Million | $3.57 Million | ▼ -920.0% |
| 2023 | -0.44x | $-20.41 Million | $46.90 Million | ▲ +78.9% |
| 2022 | -2.06x | $-20.98 Million | $10.17 Million | ▲ +47.1% |
| 2021 | -3.90x | $-23.49 Million | $6.02 Million | ▼ -152.7% |
| 2020 | -1.54x | $-8.10 Million | $5.25 Million | ▼ -673.1% |
| 2019 | 0.27x | $2.74 Million | $10.19 Million | ▲ +56.9% |
| 2018 | 0.17x | $1.36 Million | $7.95 Million | ▲ +245.2% |
| 2017 | 0.05x | $549.00K | $11.03 Million | ▲ +2727.0% |
| 2016 | 0.00x | $23.00K | $13.07 Million | ▲ +100.5% |
| 2015 | -0.32x | $-4.18 Million | $12.97 Million | ▲ +42.8% |
| 2014 | -0.56x | $-6.38 Million | $11.34 Million | ▼ -335.8% |
| 2013 | 0.24x | $1.49 Million | $6.25 Million | ▼ -47.3% |
| 2012 | 0.45x | $2.16 Million | $4.76 Million | ▲ +317.8% |
| 2011 | 0.11x | $574.00K | $5.30 Million | ▼ -86.0% |
| 2010 | 0.77x | $2.83 Million | $3.66 Million | ▲ +50.6% |
| 2009 | 0.51x | $2.50 Million | $4.88 Million | ▲ +100.4% |
| 2007 | -114.13x | $-604.00 Million | $5.29 Million | — |